AJNR Am J Neuroradiol

1. KEIR G, Mashriqi F, Caravella C, Clouston SAP, et al
   Optimization of [(18)F]-FDOPA Brain PET Acquisition Times for Assessment of Parkinsonism in the Clinical Setting.
   AJNR Am J Neuroradiol. 2024 Apr 25. doi: 10.3174/ajnr.A8207.
   

   >> Share

   
   

   
   Clin Nucl Med

2. ROGASCH JMM, Jochens HV, Metzger G, Wetz C, et al
   Keeping Up With ChatGPT: Evaluating Its Recognition and Interpretation of Nuclear Medicine Images.
   Clin Nucl Med. 2024 Apr 1. doi: 10.1097/RLU.0000000000005207.
   

   >> Share

   
   
3. DE GROOT EM, van Amerongen MJ, Ploegmakers MJM, Zegers IHA, et al
   Ruptured Baker Cyst on 18F-FDG PET/CT.
   Clin Nucl Med. 2024 Apr 19. doi: 10.1097/RLU.0000000000005242.
   

   >> Share

   
   
4. GELIKMAN DG, Mena E, Lindenberg L, Azar WS, et al
   Reducing False-Positives Due to Urinary Stagnation in the Prostatic Urethra on 18F-DCFPyL PSMA PET/CT With MRI.
   Clin Nucl Med. 2024 Apr 19. doi: 10.1097/RLU.0000000000005220.
   

   >> Share

   
   
5. DANA F, Maurer A, Muehlematter UJ, Husmann L, et al
   The Monocle Sign on 18F-FDG PET Indicates Contralateral Peripheral Facial Nerve Palsy.
   Clin Nucl Med. 2024 Apr 19. doi: 10.1097/RLU.0000000000005238.
   

   >> Share

   
   

   
   J Cereb Blood Flow Metab

6. JOYA A, Plaza-Garcia S, Padro D, Aguado L, et al
   Multimodal imaging of the role of hyperglycemia following experimental subarachnoid hemorrhage.
   J Cereb Blood Flow Metab. 2023 Sep 20:271678X231197946.
   

   >> Share

   
   

   
   J Nucl Med

7. ROSEN J, Werner JM, Ceccon GS, Rosen EK, et al
   MRI and (18)F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis.
   J Nucl Med. 2024 Apr 25:jnumed.123.266687. doi: 10.2967/jnumed.123.266687.
   

   >> Share

   
   
8. NIKITAS J, Lam E, Booker KA, Fendler WP, et al
   Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial).
   J Nucl Med. 2024 Apr 25:jnumed.123.267004. doi: 10.2967/jnumed.123.267004.
   

   >> Share

   
   
9. MINGELS C, Spencer BA, Nalbant H, Omidvari N, et al
   Dose Reduction in Pediatric Oncology Patients with Delayed Total-Body [(18)F]FDG PET/CT.
   J Nucl Med. 2024 Apr 25:jnumed.124.267521. doi: 10.2967/jnumed.124.267521.
   

   >> Share

   
   
10. DUAN H, Song H, Davidzon GA, Moradi F, et al
    Prospective Comparison of (68)Ga-NeoB and (68)Ga-PSMA-R2 PET/MRI in Patients with Biochemically Recurrent Prostate Cancer.
    J Nucl Med. 2024 Apr 25:jnumed.123.267017. doi: 10.2967/jnumed.123.267017.
    

    >> Share

    
    
11. BURKETT BJ, Johnson DR, Lowe VJ
    Evaluation of Neurodegenerative Disorders with Amyloid-beta, Tau, and Dopaminergic PET Imaging: Interpretation Pitfalls.
    J Nucl Med. 2024 Apr 25:jnumed.123.266463. doi: 10.2967/jnumed.123.266463.
    

    >> Share

    
    

    
    Neurology

12. BARATEAU L, Krache A, Da Costa A, Lecendreux M, et al
    Microglia Density and Its Association With Disease Duration, Severity, and Orexin Levels in Patients With Narcolepsy Type 1.
    Neurology. 2024;102:e209326.
    

    >> Share

    
    

    
    Nucl Med Commun

13. AL-IBRAHEEM A, Allouzi S, Abdlkadir AS, Mikhail-Lette M, et al
    PET/CT in leukemia: utility and future directions.
    Nucl Med Commun. 2024 Apr 22. doi: 10.1097/MNM.0000000000001846.
    

    >> Share

    
    

    
    Phys Med Biol

14. PILLER M, Castilla AM, Terragni G, Alozy J, et al
    Performance evaluation of the FastIC readout ASIC with emphasis on Cherenkov emission in TOF-PET.
    Phys Med Biol. 2024 Apr 24. doi: 10.1088/1361-6560.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share